Source: United Press International
“The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose. To be sold as Opvee, the spray contains the medication nalmefene hydrochloride and will be available to Americans aged 12 and older with a prescription, the FDA said. … Like its predecessor naloxone, which can be used as either a nasal spray or an injection, nalmefene hydrochloride can reverse an overdose. The difference is that naloxone wears off more quickly. This can avoid longer-lasting withdrawal symptoms, even if naloxone may need to be administered a second time as it wears off, the Associated Press reported.” (05/23/23)
https://www.upi.com/Health_News/2023/05/23/FDA-nasal-spray-overdose-Opvee/5111684852063/